The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
The 48.5p will be disputed. If HIG go right up to the extension deadline (9th Nov) to announce a decision, then it's likely the divi will be locked in and HIG will want to reduce their offer by the divi amount (as per the original RNS), so 47.5 p per share looks more likely.
There's also the outside possibility (re: the thankfully unsuccessful take-under offer for KINO) that HIG release an RNS to trash what they find about DX in their DD, and try to weasel a lower offer.
Other than the high likelihood of HIG reducing their offer to 47.5p because of the divi, I'd be wary of trying to intuit too much about this process.
Extensions and delays are the order of the day on AIM, so I'd imagine we'll get an RNS on Monday stating that talks are still on going.
I'd also imagine that if HIG retracted the offer, then the share price will drop back down to low 30s. Which is ridiculous of course, because DX should be valued much higher than 48.5p.
A short-term dip (on paper), but worth more for holders in the long-term.
48.5p per share is looking rather cheap for a business producing those kinds of numbers...
And they'll probably want to reduce it to 47.5p per share if the divi goes ahead...
I think DX is worth a lot more than that. Hopefully this will trigger a rival offer.
He scans the daily LSE top risers list and shorts what he hopes are spikes, then floods the message boards with FUD to try to cash in.
He has already deleted an account under a different name after getting it badly wrong on Afentra (AET).
JAdams5000 is a muppet.
I bought some more today while there is little attention and a gentle upward pressure.
I re-read the Interims from Sept 22 and Sept 23 and the FY results from March, and it convinced me to add to my holding :)
BOD statements in the HYs and FYs, as well as in the recent IMC presentation, are understated but very optimistic about achieving rapid growth without further dilution, or possibly even without touching the $10m credit facility.
This is where research and patience pays off. TRX is at the inflection point from loss-making to generating a profit. Once TRX can really spell out their growth in their HY and FY Reports (coming v soon), and market sentiment drags itself out of the gutter, this will fly.
BOD members put in £300,000 in July at 32-33p. I am happy with that.
I'd rather they didn't buy the dip, because it creates the possibility they may negatively word an RNS to take advantage financially. I would rather there be an incentive to get the sp back to break even for them.
Someone (or some-thing) is certainly taking advantage of the dip though...
It feels like the bottom has been reached and SCE is now (finally) on the upswing. The market probably won't like the today's bare numbers (and the market isn't really forward looking at the moment), so we might need to wait for the next TU/or FY results/significant contract wins, before seeing any real improvement in the sp.
SCE won't need cash for keeping the lights on, but may need to raise to fund the expansion. Hopefully this can be done at a later date either through loans or at least waiting for a recovery in the sp before raising.
Encouraging signs for me are Janus Henderson increasing their stake recently (at 27p) and management putting a lot of their own money in at 32-33p.
Unlikely a hostile takeover because no one owns even close enough to 30% to trigger a vote.
Buying up to 30% would cause the share price to rise significantly.
No one going for a low-ball bid would convince the other holders to sell out at that price.
Unfortunately we're stuck until the Candy Bonnier saga is resolved.
The company looks well placed for future growth, but are currently in a consolidation phase. Costs are rising and eating into the high margins at present. ACSO have a very large headcount now, bringing in-house the Digisoft developers and the other 2 acquisitions.
If the price drops a lot now, it would be a good time to buy in if you're prepared to wait 6 months for the FY results, which I expect will start to show some of the fruits of their H1 efforts.
The cross-selling potential is already showing benefits, and will only increase imo.
ACSO interims were released 13th Sept last year, so must be due any day now.
The current buying suggests others are confident of a good TU.
That is excellent news!
The FY results statement in April mentioned that TST are looking into international expansion (2 unnamed countries were mentioned as being near-term targets, while being aware that these things can take time), so most likely this Calor Ireland deal is one of them.
The phrase "major system upgrade" is pleasing :)
It is also great to read in the 100+ Logistics press release, they mentioned "secondary benefits" of using Touchstar's systems, and the TST team are "developing one or two bespoke enhancements."
This is great for 2 reasons: firstly, the additional team has expertise to customise their offerings to suit clients' needs, and secondly these probably have high margins.
Sorry, typo, 2.50p.
(250p and I could retire!)
But it's no wonder IIs are taking positions (Chris Mills at Harwood, and Dowgate Wealth have both increased their stakes within the past month) and stock is hard to find. A gem of AIM.
I managed a couple more purchases this morning, had to pay full offer 1.7p, but I have a full position here now and I can sit back and wait.
Once the Ladders Free payments come off the books, June 2024, the metrics of the bottom line will improve further and React will be producing so much free cash. The board is very smart, so I'd expect possible M&A with the spare cash or prepping the company for a buy-out.
250p minimum is my target for 2024.
Great news!
What Mkango/Maginito are hoping to set up will take enormous sums of money, time and expertise.
They can either go it alone, with massive debt, fundraising and dilution, or they can partner up with someone like CoTec. The board have made a very smart decision to do the latter.
CoTec are in this to make money, but they will only make money if we all do.
That is surely a sign that MKA have something special.
Everything is on track and looking good. The currently risk-off market might want a bit more visibility on the revenues before we see a re-rate in the share price, but all MKA can do is put down the best building blocks to ensure future success.